Shenzhen Kangtai Biological Products Co., Ltd. researches, develops, produces, and sells various types of human vaccines in China. The company's products include cell-free whitebait b-type haemophilus influenzae combined vaccine, SARS-COV-2 vaccine, recombinant hepatitis B vaccine, 23-valent pneumococcal polysaccharide vaccine, diphtheria tetanus acellular pertussis and haemophilus influenzae type b combined vaccine, haemophilus influenzae type b conjugate vaccine, measles and rubella combined with live attenuated vaccine, 13-valent pneumococcal conjugate vaccine, rabies vaccine, inactivated poliomyelitis vaccine, and HIB conjugate vaccine. It has an agreement between YTB and Yong Tai Berhad in relation to the development and commercialization of Covid-19 inactivated vaccine in Malaysia. Shenzhen Kangtai Biological Products Co., Ltd. was founded in 1992 and is based in Shenzhen, China.
Shenzhen Kangtai Biological Products Dividend Announcement
• Shenzhen Kangtai Biological Products announced a annually dividend of ¥0.20 per ordinary share which will be made payable on 2024-06-14. Ex dividend date: 2024-06-14
• Shenzhen Kangtai Biological Products annual dividend for 2024 was ¥0.20
• Shenzhen Kangtai Biological Products annual dividend for 2023 was ¥0.18
• Shenzhen Kangtai Biological Products's trailing twelve-month (TTM) dividend yield is 1.05%
• Shenzhen Kangtai Biological Products's payout ratio for the trailing twelve months (TTM) is 88.36%
• Shenzhen Kangtai Biological Products's dividend growth over the last five years (2018-2023) was 17.69% year
Shenzhen Kangtai Biological Products Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-06-14 | ¥0.20 | annually | 2024-06-14 |
2023-10-13 | ¥0.18 | annually | 2023-10-13 |
2022-06-02 | ¥0.85 | annually | 2022-06-02 |
2021-09-29 | ¥0.30 | annually | 2021-09-29 |
2020-08-17 | ¥0.30 | annually | 2020-08-17 |
2019-07-05 | ¥0.25 | annually | 2019-07-05 |
2018-06-13 | ¥0.08 | annually | 2018-06-13 |
2017-06-07 | ¥0.06 | annually | 2017-06-07 |
Shenzhen Kangtai Biological Products Dividend per year
Shenzhen Kangtai Biological Products Dividend growth
Shenzhen Kangtai Biological Products Dividend Yield
Shenzhen Kangtai Biological Products current trailing twelve-month (TTM) dividend yield is 1.05%. Interested in purchasing Shenzhen Kangtai Biological Products stock? Use our calculator to estimate your expected dividend yield:
Shenzhen Kangtai Biological Products Financial Ratios
Shenzhen Kangtai Biological Products Dividend FAQ
Other factors to consider when evaluating Shenzhen Kangtai Biological Products as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Shenzhen Kangtai Biological Products stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Shenzhen Kangtai Biological Products's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Shenzhen Kangtai Biological Products publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Shenzhen Kangtai Biological Products distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Shenzhen Kangtai Biological Products are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Shenzhen Kangtai Biological Products sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Shenzhen Kangtai Biological Products distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Shenzhen Kangtai Biological Products declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Shenzhen Kangtai Biological Products's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Shenzhen Kangtai Biological Products's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.